Here’s why everything changes once you’ve hit $2M for retirement (and not for the better). Can you protect your riches?

If you have $2 million in retirement savings, congratulations. That’s well above the $1.26 million that Americans, according ...

Emerge's 2025 Story of the Year: How the AI Race Fractured the Global Tech Order

NOTE: Images in exported zip file from Google Docs may not appear in the same order as they do in your doc. Please check the ...

Moog Inc. (NYSE:MOG.A) Shares Could Be 32% Below Their Intrinsic Value Estimate

Key Insights Moog's estimated fair value is US$365 based on 2 Stage Free Cash Flow to Equity Moog is estimated to ...

Has the Tempus AI Rally Gone Too Far After Its 89% Surge in 2025?

If you are wondering whether Tempus AI is still a smart buy after its big run, or if the easy money has already been made, you are not alone. This breakdown will help you decide if the current price ...

A look at the experts racing to decode Trump’s tariff rules

After a half-century immersed in the world of trade, customs broker Amy Magnus thought she’d seen it all, navigating ...

Does Iberdrola’s Strong Multi Year Rally Still Leave Upside In 2025?

If you are wondering whether Iberdrola is still good value after such a strong run, or if you might be late to the party, this breakdown will help you decide whether the current price makes sense. The ...

ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive Early Breast Cancer

ENHERTU® Granted Breakthrough Therapy Designation in the U.S. as Post-Neoadjuvant Therapy for Patients with HER2 Positive ...
EuropaWire

Institute of Cancer Research study identifies blood-based marker of chemotherapy resistance in advanced prostate cancer

The Institute of Cancer Research has led a study showing that chromosomal instability in circulating tumour cells can predict resistance to cabazitaxel in men with advanced prostate cancer. Using ...